COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA
- 1 March 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8586) , 611-613
- https://doi.org/10.1016/s0140-6736(88)91414-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemiaClinical Pharmacology & Therapeutics, 1986
- SYNVINOLIN IN HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemiaAtherosclerosis, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- A Simple Turbidimetric Method for the Determination of Serum CholesterolAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1969